Evidence map›Paper›PMID 25659124›Full record

ArticlePLoS genetics2015

Modeling of the human alveolar rhabdomyosarcoma Pax3-Foxo1 chromosome translocation in mouse myoblasts using CRISPR-Cas9 nuclease.

Irina V Lagutina, Virginia Valentine, Fabrizio Picchione, Frank Harwood, Marcus B Valentine, Barbara Villarejo-Balcells, Jaime J Carvajal, Gerard C Grosveld

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. CRISPR in cancer biology and therapy.Nature reviews. Cancer · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. The clear cell sarcoma functional genomic landscape.The Journal of clinical investigation · 2021
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Transgenic Mouse Models in Cancer Research.Frontiers in oncology · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Irina V LagutinaDepartments of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Virginia ValentineTumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Fabrizio PicchioneDepartments of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Frank HarwoodDepartments of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Marcus B ValentineTumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Barbara Villarejo-BalcellsDivision of Cancer Biology, The Institute of Cancer Research, London, United Kingdom.
Jaime J CarvajalDivision of Cancer Biology, The Institute of Cancer Research, London, United Kingdom; Centro Andaluz de Biología del Desarrollo (CSIC/UPO/JA), Sevilla, Spain.
Gerard C GrosveldDepartments of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
St. Jude Children's Research Hospital · USCentro Andaluz de Biología del Desarrollo · ESInstitute of Cancer Research · GB

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Cancer Research UK C1178/A4520NCI NIH HHS 5P30CA021765-34NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

Many recurrent chromosome translocations in cancer result in the generation of fusion genes that are directly implicated in the tumorigenic process. Precise modeling of the effects of cancer fusion genes in mice has been inaccurate, as constructs of fusion genes often completely or partially lack the correct regulatory sequences. The reciprocal t(2;13)(q36.1;q14.1) in human alveolar rhabdomyosarcoma (A-RMS) creates a pathognomonic PAX3-FOXO1 fusion gene. In vivo mimicking of this translocation in mice is complicated by the fact that Pax3 and Foxo1 are in opposite orientation on their respective chromosomes, precluding formation of a functional Pax3-Foxo1 fusion via a simple translocation. To circumvent this problem, we irreversibly inverted the orientation of a 4.9 Mb syntenic fragment on chromosome 3, encompassing Foxo1, by using Cre-mediated recombination of two pairs of unrelated oppositely oriented LoxP sites situated at the borders of the syntenic region. We tested if spatial proximity of the Pax3 and Foxo1 loci in myoblasts of mice homozygous for the inversion facilitated Pax3-Foxo1 fusion gene formation upon induction of targeted CRISPR-Cas9 nuclease-induced DNA double strand breaks in Pax3 and Foxo1. Fluorescent in situ hybridization indicated that fore limb myoblasts show a higher frequency of Pax3/Foxo1 co-localization than hind limb myoblasts. Indeed, more fusion genes were generated in fore limb myoblasts via a reciprocal t(1;3), which expressed correctly spliced Pax3-Foxo1 mRNA encoding Pax3-Foxo1 fusion protein. We conclude that locus proximity facilitates chromosome translocation upon induction of DNA double strand breaks. Given that the Pax3-Foxo1 fusion gene will contain all the regulatory sequences necessary for precise regulation of its expression, we propose that CRISPR-Cas9 provides a novel means to faithfully model human diseases caused by chromosome translocation in mice.

Indexed as

AnimalsCell Line, TumorCRISPR-Cas SystemsGene Expression Regulation, NeoplasticHumansIn Situ Hybridization, FluorescenceMiceMyoblastsOncogene Proteins, FusionPaired Box Transcription FactorsRhabdomyosarcoma, AlveolarRNA, MessengerTranslocation, GeneticOncogene Proteins, FusionPaired Box Transcription FactorsPAX3-FOXO1A fusion protein, humanRNA, Messenger

Identifiers

PMID25659124
PMCPMC4319822
OpenAlexW2078851085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.